DE4122706C1 - - Google Patents

Info

Publication number
DE4122706C1
DE4122706C1 DE4122706A DE4122706A DE4122706C1 DE 4122706 C1 DE4122706 C1 DE 4122706C1 DE 4122706 A DE4122706 A DE 4122706A DE 4122706 A DE4122706 A DE 4122706A DE 4122706 C1 DE4122706 C1 DE 4122706C1
Authority
DE
Germany
Prior art keywords
corydalis
extract
eschscholtzia
extracts
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE4122706A
Other languages
German (de)
English (en)
Inventor
Werner Dipl.-Biol. Dr.Rer.Nat. 5400 Koblenz De Schneider
E.F. Prof. Dr. 8031 Groebenzell De Elstner
E. Dipl.-Biol. Dr. 8042 Oberschleissheim De Kleber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Priority to DE4122706A priority Critical patent/DE4122706C1/de
Priority to CA002072950A priority patent/CA2072950A1/en
Priority to AU19370/92A priority patent/AU652262B2/en
Priority to IL102410A priority patent/IL102410A/en
Priority to YU67492A priority patent/YU48554B/sh
Priority to ZA925059A priority patent/ZA925059B/xx
Priority to US07/909,675 priority patent/US5308619A/en
Priority to SU925052267A priority patent/RU2072859C1/ru
Priority to MX9204011A priority patent/MX9204011A/es
Priority to SI19929200138A priority patent/SI9200138A/sl
Priority to PT100668A priority patent/PT100668B/pt
Priority to IE922226A priority patent/IE74691B1/en
Priority to EG37092A priority patent/EG20140A/xx
Priority to KR1019920012112A priority patent/KR100225010B1/ko
Priority to DK92111709.9T priority patent/DK0535317T3/da
Priority to SK2143-92A priority patent/SK279531B6/sk
Priority to CS922143A priority patent/CZ279915B6/cs
Priority to DE59206608T priority patent/DE59206608D1/de
Priority to EP92111709A priority patent/EP0535317B1/de
Priority to JP4182626A priority patent/JPH085796B2/ja
Priority to HU9202274A priority patent/HUT61668A/hu
Priority to AT92111709T priority patent/ATE139446T1/de
Priority to ES92111709T priority patent/ES2088053T3/es
Application granted granted Critical
Publication of DE4122706C1 publication Critical patent/DE4122706C1/de
Priority to UA93002403A priority patent/UA26971C2/uk
Priority to EE9400046A priority patent/EE03169B1/xx
Priority to MD95-0171A priority patent/MD1139G2/ro
Priority to GR960401185T priority patent/GR3020289T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE4122706A 1991-07-09 1991-07-09 Expired - Fee Related DE4122706C1 (enExample)

Priority Applications (27)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09
CA002072950A CA2072950A1 (en) 1991-07-09 1992-07-02 Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunction
AU19370/92A AU652262B2 (en) 1991-07-09 1992-07-02 Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
IL102410A IL102410A (en) 1991-07-09 1992-07-03 Pharmaceutical preparation containing a combination of extracts of Corridlis and Eshulation
YU67492A YU48554B (sh) 1991-07-09 1992-07-06 Postupak za dobijanje farmaceutskog sredstva
ZA925059A ZA925059B (en) 1991-07-09 1992-07-07 Pharmaceutical and its use for the treatment of a state of agitation and nerve dysfunctions
US07/909,675 US5308619A (en) 1991-07-09 1992-07-07 Pharmaceutical and its use for the treatment of states of agitation and nervous dysfunctions
MX9204011A MX9204011A (es) 1991-07-09 1992-07-08 Composicion farmaceutica que comprende como ingredientes activos extractos obtenidos por extraccion del alcohol.
SI19929200138A SI9200138A (en) 1991-07-09 1992-07-08 Pharmaceutical product for the treatment of states of acitation and nerve dysfunctions
PT100668A PT100668B (pt) 1991-07-09 1992-07-08 Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos
IE922226A IE74691B1 (en) 1991-07-09 1992-07-08 Pharmaceutical for the treatment of states of agitation and nerve dysfunctions
EG37092A EG20140A (en) 1991-07-09 1992-07-08 A process for preparing of pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
KR1019920012112A KR100225010B1 (ko) 1991-07-09 1992-07-08 초조상태 및신경기능 장해의 치료용 약학 조성물
SU925052267A RU2072859C1 (ru) 1991-07-09 1992-07-08 Растительный экстракт, обладающий допаминергической активностью
DK92111709.9T DK0535317T3 (da) 1991-07-09 1992-07-09 Lægemiddel til lindring af ophidselstilstande og nervedysfunktioner
CS922143A CZ279915B6 (cs) 1991-07-09 1992-07-09 Léčivo k léčení stavů vzrušení a nervových poruch a jeho použití
DE59206608T DE59206608D1 (de) 1991-07-09 1992-07-09 Arzneimittel zur Behandlung von Erregungszuständen und Nervendysfunktionen
EP92111709A EP0535317B1 (de) 1991-07-09 1992-07-09 Arzneimittel zur Behandlung von Erregungszuständen und Nervendysfunktionen
JP4182626A JPH085796B2 (ja) 1991-07-09 1992-07-09 激越状態及び神経機能不全の治療用製剤
HU9202274A HUT61668A (en) 1991-07-09 1992-07-09 Process for producing pharmaceutical compositions for treating over-excitements and nerval troubles
AT92111709T ATE139446T1 (de) 1991-07-09 1992-07-09 Arzneimittel zur behandlung von erregungszuständen und nervendysfunktionen
ES92111709T ES2088053T3 (es) 1991-07-09 1992-07-09 Medicamento y empleo del mismo para el tratamiento de estados de excitacion y disfunciones nerviosas.
SK2143-92A SK279531B6 (sk) 1991-07-09 1992-07-09 Farmaceutický prostriedok na liečenie stavov vzruš
UA93002403A UA26971C2 (uk) 1991-07-09 1993-03-12 Рослиhhий екстракт, який має допаміhергічhу активhість
EE9400046A EE03169B1 (et) 1991-07-09 1994-08-09 Ravim erutusseisundite ja närvitalitlushäirete leevendamiseks või seiskamiseks
MD95-0171A MD1139G2 (ro) 1991-07-09 1994-12-30 Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase
GR960401185T GR3020289T3 (en) 1991-07-09 1996-06-20 Drug for the treatment of agitation state and nerve dysfonction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09

Publications (1)

Publication Number Publication Date
DE4122706C1 true DE4122706C1 (enExample) 1993-03-04

Family

ID=6435763

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4122706A Expired - Fee Related DE4122706C1 (enExample) 1991-07-09 1991-07-09
DE59206608T Expired - Fee Related DE59206608D1 (de) 1991-07-09 1992-07-09 Arzneimittel zur Behandlung von Erregungszuständen und Nervendysfunktionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59206608T Expired - Fee Related DE59206608D1 (de) 1991-07-09 1992-07-09 Arzneimittel zur Behandlung von Erregungszuständen und Nervendysfunktionen

Country Status (26)

Country Link
US (1) US5308619A (enExample)
EP (1) EP0535317B1 (enExample)
JP (1) JPH085796B2 (enExample)
KR (1) KR100225010B1 (enExample)
AT (1) ATE139446T1 (enExample)
AU (1) AU652262B2 (enExample)
CA (1) CA2072950A1 (enExample)
CZ (1) CZ279915B6 (enExample)
DE (2) DE4122706C1 (enExample)
DK (1) DK0535317T3 (enExample)
EE (1) EE03169B1 (enExample)
EG (1) EG20140A (enExample)
ES (1) ES2088053T3 (enExample)
GR (1) GR3020289T3 (enExample)
HU (1) HUT61668A (enExample)
IE (1) IE74691B1 (enExample)
IL (1) IL102410A (enExample)
MD (1) MD1139G2 (enExample)
MX (1) MX9204011A (enExample)
PT (1) PT100668B (enExample)
RU (1) RU2072859C1 (enExample)
SI (1) SI9200138A (enExample)
SK (1) SK279531B6 (enExample)
UA (1) UA26971C2 (enExample)
YU (1) YU48554B (enExample)
ZA (1) ZA925059B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656791A4 (en) * 1992-07-06 1997-08-20 Childrens Medical Center THERAPEUTIC COMPOSITIONS AND METHODS BASED ON 2,7,9-TRICARBOXY-PYRROLOQUINOLEINE (PQQ).

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
PT1066042E (pt) * 1998-03-26 2006-12-29 Phytopharm Plc Saponinas esteroides para o tratamento de doença de alzheimer
NZ514253A (en) 1999-03-11 2003-06-30 Zeachem Inc Process for producing ethanol
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
NZ586246A (en) * 2004-01-29 2013-03-28 Zeachem Inc Recovery of organic acids from a fermentation broth
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (enExample) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Arch. Int. Pharmacodyn Ther 258(1) 1982 *
Chem. Abstracts 111(21) 187306 (1989) *
Chem. Abstracts 95(15) 129425h (1981) *
Chem. Abstracts 96(15) 115738w (1982) *
HOPPE, H.A.: Drogenkunde, Bd. 1, 8. Aufl. Walter de Gruyter, Berlin 1975, S. 472 u. 345 u. 346 *
Mem. Int. OswaldoCruz Rio J. 86 1991 *
Phytochem. (OF) 30(9) 1991 *
WEIß, R.: Lehrbuch der Phytotherapie, Hippokrates Stuttgart, 6. Aufl. 1985, S. 377, 355, 356 *
Yakugaku Zasshi 108(5) 1988 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656791A4 (en) * 1992-07-06 1997-08-20 Childrens Medical Center THERAPEUTIC COMPOSITIONS AND METHODS BASED ON 2,7,9-TRICARBOXY-PYRROLOQUINOLEINE (PQQ).

Also Published As

Publication number Publication date
EG20140A (en) 1997-07-31
GR3020289T3 (en) 1996-09-30
EE03169B1 (et) 1999-04-15
IE922226A1 (en) 1993-01-13
PT100668B (pt) 1999-08-31
MD1139G2 (ro) 1999-10-31
ES2088053T3 (es) 1996-08-01
KR100225010B1 (ko) 1999-10-15
JPH085796B2 (ja) 1996-01-24
ATE139446T1 (de) 1996-07-15
RU2072859C1 (ru) 1997-02-10
IL102410A (en) 1998-02-22
JPH0753392A (ja) 1995-02-28
AU1937092A (en) 1993-01-14
UA26971C2 (uk) 2000-02-28
CZ214392A3 (en) 1993-02-17
CA2072950A1 (en) 1993-01-10
SK214392A3 (en) 1994-11-09
ZA925059B (en) 1993-04-28
HUT61668A (en) 1993-03-01
IE74691B1 (en) 1997-07-30
MD1139F2 (en) 1999-01-31
YU48554B (sh) 1998-11-05
KR930001926A (ko) 1993-02-22
SI9200138A (en) 1993-03-31
YU67492A (sr) 1996-01-09
US5308619A (en) 1994-05-03
MD950171A (en) 1996-06-28
AU652262B2 (en) 1994-08-18
EP0535317B1 (de) 1996-06-19
SK279531B6 (sk) 1998-12-02
PT100668A (pt) 1993-09-30
HU9202274D0 (en) 1992-10-28
DK0535317T3 (da) 1996-07-15
EP0535317A1 (de) 1993-04-07
CZ279915B6 (cs) 1995-08-16
MX9204011A (es) 1993-07-01
IL102410A0 (en) 1993-01-14
DE59206608D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
Kar et al. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice
CH685282A5 (de) Antigeschwulstmittel und Verfahren zu ihrer Herstellung.
DE4122706C1 (enExample)
WO2003013562A1 (de) Artischockenblätterextrakte
EP1487468B1 (de) Pflanzenextrakte und deren anwendung
DE3022281C2 (de) Von Alkaloiden befreiter wäßriger Extrakt aus Aconitwurzeln und diesen Extrakt als Wirkstoff enthaltende pharmazeutische Zusammensetzung
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
DE2513940A1 (de) Pharmazeutische zubereitung
EP0897302B1 (de) Harpagosid-angereicherter extrakt aus harpagophytum procumbens und verfahren zu seiner herstellung
EP0397646B1 (de) Pharmazeutisches Präparat zur Behandlung von Lebererkrankungen
EP0904092B1 (de) Gereinigter extrakt von harpagophytum procumbens und/oder harpagophytum zeyheri dence, verfahren zu seiner herstellung und seine verwendung
DE69622704T2 (de) Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht
DE102018127408A1 (de) Cranberry-Extrakt-PAC-A-Zusammensetzung und dessen Verwendung bei der Prävention und/oder Behandlung von Harnwegsinfekten
DE202023001867U1 (de) Formulierung umfassend mindestens eine Kresse-Art
EP2282751B1 (de) Kompartimentspezifische pflanzenextraktkombination aus ginkgo biloba- und ginseng-extrakt mit tandemwirkung
DE69619846T2 (de) Prophylaktische absorbierbare zubereitung mit protektiver wirkung gegen elektromagnetische wellen mit ionisierendem oder nicht ionisierendem effekt
DE4100361C1 (enExample)
EP0820771A2 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
WO1998038995A1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
DE102021104285A1 (de) Pulverförmiges Nahrungsergänzungsmittel zur Herstellung eines Getränks
DE69936773T2 (de) Behandlung von depression und zusammensetzungen dazu
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2659465C2 (de) Pflanzliche Wirkstoffextrakte aus Hypoxidaceen und ihre Anwendung
DE19915102A1 (de) Verwendung von Limonen zur Behandlung oxidativer Zellschädigungen
Güney et al. ASSESSMENT OF ANTIOXIDANT AND ANTIDIABETIC PROPERTIES OF DATURA INNOXIA MILL. SEED EXTRACTS OBTAINED WITH SOLVENTS WITH DIFFERENT POLARITIES

Legal Events

Date Code Title Description
8100 Publication of patent without earlier publication of application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee